Value sales of dermatologicals are maintaining positive growth in Georgia in 2025, mainly encouraged by price increases. Meanwhile, volume sales are being supported by “beauty-from-within” trends. Georgian consumers are paying more attention to their skin, seeing it as a sign of their overall health, not just related to how they look, which means that consumers will be quicker to use skin remedies when problems arise. For everyday minor skin issues, consumers are increasingly choosing to treat t

Dermatologicals continued to increase in Estonia in 2025, with growth concentrated in everyday infection and irritation care. The strongest uplifts were in topical germicidals/antiseptics, haemorrhoid treatments and cold sore treatments, helped by a hygiene mindset that persisted post-pandemic, more people engaging in sporting activities and sauna usage, ageing, and more sedentary work patterns. Vaginal antifungals outperformed topical antifungals as women sought fast, targeted therapies and pha

Value sales of dermatologicals are seeing positive growth in the Dominican Republic in 2025, at a fair but not particularly strong rate. Dermatological products show a mixed behaviour in retail sales values, as cautious purchasing behaviour has led consumers to opt for more economical options, such as hair loss treatments or medicated shampoos. Local consumers often prefer products that do not include active ingredients in their formulations, in personal care shampoo brands that promote attribut

Dermatologicals in Switzerland continues to grow steadily in value terms, fuelled by outdoor lifestyles and leisure activity. Consumers are spending more time socialising and spending more time away from home, at work, school, the gym and public swimming pools. Such lifestyles have contributed to higher demand for various dermatologicals, including antifungals, antipruritics, antiparasitics, topical germicidals and cold sore treatments. For example, increased time spent outside exposes people to

Dermatologicals is registering solid growth in 2025, driven by rising consumer demand for hair loss treatments. This trend reflects a broader pursuit of beauty and self-care, particularly as individuals seek ways to regain control and confidence amid ongoing national and global stressors, such as economic uncertainty, social instability, and environmental concerns. Hair loss, often linked to stress, poor nutrition, and hormonal imbalances, has become a more openly addressed issue, leading to inc

Sales of dermatologicals have posted a moderate increase in current value terms in 2025. Despite looming tariffs and lower consumer confidence, with a pullback in spending across the market, sales of dermatologicals have benefited from minimal price increases and consumers stockpiling essentials in the first half of 2025. Categories connected to hair and scalp health came out on top in 2025 as consumers increasingly view hair and scalp health as integral to their overall health and wellness. Thr

In 2025, retail value sales of dermatologicals in Norway are set to increase, continuing the stable growth trend observed in 2023 and 2024. This category remains resilient due to its essential nature, when symptoms arise, consumers tend to act quickly. The consistent demand is driven by the need for effective, trusted treatments across a range of common but often sensitive conditions.

Dermatologicals in the United Arab Emirates is projected to continue to see healthy retail current value growth over 2025. Increased health awareness, wider product availability and ongoing innovation are accelerating demand across dermatologicals and expanding the category’s potential in the United Arab Emirates. The rising popularity of the biggest seller in terms of retail value sales, hair loss treatments, is a key factor fuelling growth, as more consumers seek effective solutions. Hair loss

Retail value sales of dermatologicals are set to rise in current terms in Japan in 2025. The category is expected to see value sales grow despite stagnant volumes due to rising unit prices and the expansion of high-value-added products. Health and personal care stores and pharmacies remain the primary sales channels, but in categories where privacy is a key concern - such as hair regrowth treatments - consumers are increasingly turning to e-commerce for both information and purchases. This shift

Value sales of dermatologicals in Bulgaria increased in 2025. The Bulgarian dermatologicals market benefited from a positive performance, shaped by a mix of environmental and lifestyle factors. Pollution and climate change contributed to longer allergy seasons and higher insect activity, prompting demand for topical allergy and itch remedies. Warmer weather conditions led to more cases of mosquito bites, rashes and allergic reactions, while stress and sedentary lifestyles also drove demand for t

Value sales of dermatologicals recorded a slight increase in Belgium in 2025. However, the category as a whole faced a decline in retail volume, underscoring its status as a non-essential segment for many consumers. In periods of economic uncertainty or shifting personal priorities, purchases in dermatologicals are often delayed or deprioritised in favour of more immediate health needs. Furthermore, the overall maturity of the market limits opportunities for innovation or expanded usage, contrib

Value sales of dermatologicals in the Czech Republic increased in 2025, with growth supported by rising demand for hair loss treatments, paediatric dermatologicals, cold sore remedies, and haemorrhoid treatments. Appearance-related concerns continued to boost interest in hair loss solutions and medicated shampoos, while greater participation in sports and outdoor activities sustained demand for cold sore remedies. The expansion of product ranges both in-store and online, combined with heightened

Dermatologicals in Canada saw an increase in value sales over 2025, driven by growth across all categories. A combination of factors are supporting this positive performance. Chief among them is the growing consumer awareness of skin health and its relative importance to consumers. The growing population aged 65+ typically encounters more dermatological health issues, which is providing stimulus to the category. Canada’s immigration-driven population is also increasing the potential consumer bas

Retail value sales of dermatologicals are set to decline in current terms in South Korea in 2025. Vaginal antifungals is, however, set to see an upturn in current value sales during the year. Although this category slightly overlaps with the beauty and personal care market - particularly with products like intimate washes - it maintains its distinct position by focusing on therapeutic benefits. Brands have been actively educating consumers about the unique value of vaginal antifungals, which has

In 2025, the value sales of dermatological products in Colombia are recovering, achieving low single-digit growth after a decline in 2024. This recovery is occurring amid ongoing uncertainty within the public health system, with a notable shift from institutional sales to the retail channel as patients face delays and difficulties in securing appointments. Additionally, the increasing consumer confidence in generic and private label alternatives, coupled with their affordability, has further pro

Retail value sales of dermatologicals rose in Cameroon in 2025, driven by rising cosmetic usage and environmental challenges. A pervasive social media culture has intensified beauty standards, fuelling a surge in cosmetic product consumption. This is particularly the case for skin lightening creams, where usage prevalence is estimated between 26.33% and 46.33%. This trend has directly contributed to increased cases of dermatitis, acne, and hyperpigmentation. Consequently, demand for dermatologic

In 2025, dermatologicals in Mexico continues to show strong and stable retail current value growth, in line with previous years. While the category does not typically experience major growth drivers, its performance remains steady due to persistent demand for products related to skin care and relief from common conditions. Personal hygiene remains an established priority among Mexican consumers - a habit that was reinforced during the COVID-19 pandemic and has endured in the post-pandemic contex

In 2025, dermatologicals in China continues see steady and solid value growth, driven by expanding middle-class demand, rising skin-health awareness and the shift towards online purchasing. However, growth rates differ markedly across segments. The most dynamic subcategory in terms of value growth in 2025 is hair loss treatments, driven by solutions featuring minoxidil. These sorts of offerings benefit from strong urban demand, a growing focus on self-care and buoyant online distribution.

Retail value sales of dermatologicals are set to rise in current terms in the UK in 2025, reflecting growing consumer demand for skin health solutions outside of specialist intervention and more general products in the beauty category. This growth is being driven by heightened awareness of skin conditions, increased self-care habits, and the expansion of product offerings across both therapeutic and cosmetic segments. Consumers are showing a strong preference for trusted brands, particularly in

Dermatologicals in Germany is expected to experience strong retail current value sales growth in 2025, marginally higher than in 2023 and 2024. This growth in the category is being driven by the prevalence of dermatological issues among a large portion of the population. Skin infections, dermatitis and eczema are particularly prevalent, especially in summer amidst high temperatures. These complaints are usually managed, rather than cured with dermatological products. Consequently, topical treatm

Retail value sales of dermatologicals are expected to rise in current terms in Chile in 2025. The category continues to grow in line with previous years, showing a stable performance without major fluctuations. While the category is generally characterised by its steadiness and did not experience substantial growth following the lifting of COVID-19 restrictions, certain factors are contributing to continued demand. Antifungal products, for instance, benefit from the growing interest in healthier

Value sales of dermatologicals in Azerbaijan increased in 2025, driven by growing consumer interest in skincare and maintaining skin health, including the prevention and treatment of various dermatological conditions. This growth was further supported by a rise in skin issues linked to environmental factors, stress, and modern lifestyles.

Dermatologicals in Austria continued to record steady value growth in 2025, supported by a wide range of lifestyle and demographic factors that contribute to skin health needs. The resumption of social and leisure activities after the pandemic, such as gym visits, swimming pools and schools or childcare centres, sustained demand for antifungals and antiparasitics. At the same time, demographic trends such as an ageing population and a high prevalence of overweight and obesity created additional

Sales of dermatologicals have seen steady growth in current value terms in 2025, with the performance of select categories driving the growth trajectory. Core categories within dermatologicals include topical germicidals/antiseptics, which registered a robust performance over the review period, in addition to nappy (diaper) rash treatments, cold sore treatments, haemorrhoid treatments and antiparasitics/lice (head and body) treatments. Nevertheless, the most dynamic category in 2025 has been hai